Analysts have trimmed their fair value estimate for Boston Scientific from US$100.31 to US$95.75, a reset that anchors the latest round of target updates. This shift lines up with research coverage ...
Original Image Link
Source:finance.yahoo.com
Original Image Link
Source:finance.yahoo.com
Posted: 2026-04-24 04:08:00

















